Literature DB >> 10395039

Cytoplasmic expression of hepatitis B core antigen in chronic hepatitis B virus infection: role of precore stop mutants.

Y N Park1, K H Han, K S Kim, J P Chung, S Kim, C Park.   

Abstract

AIMS/
BACKGROUND: The cytoplasmic expression of HBcAg is a possible target of immune hepatocytolysis and it is important for the pathogenesis of hepatic injury in chronic hepatitis B virus (HBV) infection. Cytoplasmic HBcAg expression has been suggested to be related to the precore sequence of HBV, HBV DNA level or cell cycle of hepatocytes and the aim of this study was to understand its mechanism. MATERIAL/
METHODS: We studied the expression pattern of HBcAg and its relationship to serum HBV DNA levels, cell proliferation activity of hepatocytes and precore mutation using 66 patients' sera and biopsied liver specimens of chronic hepatitis B.
RESULTS: The expression patterns of HBcAg were cytoplasmic predominant (CP) in 17 cases, nuclear and cytoplasmic (NC) in 10 cases and nuclear predominant (NP) in 9 cases and negative in 30 cases. CP expression cases showed a higher grade of hepatitis activity than NP expression cases. Serum HBV DNA levels showed a wide range and there was no significant difference according to the expression pattern of HBcAg. Cell proliferation activity of hepatocytes, measured by Ki-67 (MIB-1) labelling index was higher in CP expression cases than in NP expression cases and it was also significantly higher in cases of high grade than in low grade hepatitis activity. The precore region was evaluated by primer extension assay in 51 cases and there were 16 cases of 1896 precore mutant, 23 cases of wild type, 12 cases of mixed infection of 1896 precore mutant type and wild type. CP expression of HBcAg was significantly more frequent in 1896 precore mutant cases (86%) than in wild type cases (26%).
CONCLUSION: CP expression of HBcAg is the major pattern of 1896 precore mutant cases and it might be involved in the severe liver injury of precore mutants. One of the mechanisms regulating CP HBcAg expression is suggested to be precore mutation of HBV as well as cell cycle of hepatocyte.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10395039     DOI: 10.1111/j.1478-3231.1999.tb00036.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  8 in total

1.  Detection of T lymphocyte subsets and mIL-2R on surface of PBMC in patients with hepatitis B.

Authors:  Ke-Xia Wang; Jiang-Long Peng; Xue-Feng Wang; Ye Tian; Jian Wang; Chao-Pin Li
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

2.  Dynamic changes of HBV DNA in serum and peripheral blood mononuclear cells of chronic hepatitis patients after lamivudine treatment.

Authors:  Chang-Zheng Ke; Yue Chen; Zuo-Jiong Gong; Zhong-Ji Meng; Li Liu; Ze-Jiu Ren; Zuo-Hua Zhou
Journal:  World J Gastroenterol       Date:  2006-07-07       Impact factor: 5.742

Review 3.  What is expected from the pathologist in the diagnosis of viral hepatitis?

Authors:  Helmut Denk
Journal:  Virchows Arch       Date:  2011-02-26       Impact factor: 4.064

4.  Core antigen expression is associated with hepatic necroinflammation in e antigen-negative chronic hepatitis B patients with low DNA loads.

Authors:  Yi-Hsiang Huang; Hung-Hsu Hung; Che-Chang Chan; Chiung-Ru Lai; Chi-Jen Chu; Teh-Ia Huo; Pui-Ching Lee; Chien-Wei Su; Keng-Hsin Lan; Hui-Chun Huang; I-Cheng Lee; Han-Chieh Lin; Shou-Dong Lee
Journal:  Clin Vaccine Immunol       Date:  2010-04-28

5.  Abnormal immunity and gene mutation in patients with severe hepatitis-B.

Authors:  Jing-Yan Wang; Pei Liu
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

Review 6.  Quasispecies structure, cornerstone of hepatitis B virus infection: mass sequencing approach.

Authors:  Francisco Rodriguez-Frias; Maria Buti; David Tabernero; Maria Homs
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

Review 7.  Nuclear Import of Hepatitis B Virus Capsids and Genome.

Authors:  Lara Gallucci; Michael Kann
Journal:  Viruses       Date:  2017-01-21       Impact factor: 5.048

8.  PRMT5: A novel regulator of Hepatitis B virus replication and an arginine methylase of HBV core.

Authors:  Barbora Lubyova; Jan Hodek; Ales Zabransky; Hana Prouzova; Martin Hubalek; Ivan Hirsch; Jan Weber
Journal:  PLoS One       Date:  2017-10-24       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.